Salbutamol delivered via Metered Dose Inhaler and Spacer versus Nebuliser to induce bronchodilatation during spirometry

Recruiting

• Conditions: Asthma; Chronic Obstructive Pulmonary Disease (COPD); Respiratory - Asthma; Respiratory - Chronic obstructive pulmonary disease

• Registration Number: ACTRN12607000149460
• Lead Sponsor: Respiratory Department, Box Hill Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-02-28
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

All patients with known asthma or chronic obstructive airways disease (COPD) are eligible to be enrolled in the study.

Exclusion Criteria

The following categories of patients will be excluded from the study:• Patients under 18 years of age• Known pregnancy• Breast feeding• Known allergy to Salbutamol• Having had the following bronchodilators within the specified times below:o Salbutamol within 8 hours of the testo Long acting B-agonist (Salmeterol or Eformoterol) and theophylline within 24 hourso Tiotropium within 72 hourso Montelukast within 4 days.

Study & Design

• Study Type: Interventional
• Study Design: Not specified